Trial | NCT01174524  Report issue

Official Title

Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    ethinyl estradiol ...

  • Study Participants

    100
The purpose of this study is to determine whether low-dose contraceptive pills are effective in the improvement of quality of life in patients in the different phases of menacme.
Study Started
Jan 31
2008
Primary Completion
Nov 30
2008
Study Completion
Nov 30
2008
Last Update
Aug 03
2010
Estimate

Drug gestoden 60 mcg

gestoden 60 mcg, once a day, administered in 24/4 regimen.

  • Other names: oral contraceptives, quality of life, gestodene and ethinyl estradiol

Drug ethinylestradiol 15 mcg

ethinylestradiol 15 mcg, once a day, administered in 24/4 regimen

  • Other names: oral contraceptives, gestodene and ethinyl estradiol, quality of life

gestoden and ethinylestradiol Experimental

Gestoden 60 mcg plus ethinylestradiol 15 mcg, once a day, administered in 24∕4 regimen, for three months. The use of gestoden and ethinylestradiol can do an improvement of the quality of life before and after the use of the drug.Numerous large clinical trials have shown that this combination is as effective in preventing pregnancies as other oral contraceptives presently on the market. Irregular bleeding and spotting rates appear to be at least as good as older formulations. In general, the incidence of side effects associated with the progestin and estrogen components tends to be low, with very little impact on lipid and carbohydrate metabolism. . For this, the regimen can ameliorate the quality of life of the patients.

Criteria 

Inclusion Criteria:

Fertile women with indication of use of contraceptive pills

Exclusion Criteria:

Fertile women with any surgical contraceptive method
Women in menopause
Diseases the forbidden the use of the drug
No Results Posted